 | • レポートコード：GIR-107A11902 • 出版社/出版日：GlobalInfoResearch / 2021年7月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、109ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、低分子干渉RNA（siRNA）治療のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。低分子干渉RNA（siRNA）治療の種類別市場規模（リポソーム全身療法、ナノ粒子全身療法、その他）、用途別市場規模（病院、研究機関、製薬・バイオテクノロジー企業、学術機関、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・低分子干渉RNA（siRNA）治療の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：GE、Horizon Discovery、Thermo Scientific、OPKO Health、AInylam Pharmaceuticals、Arrowhead Research、Sanofi Genzyme、Genecon Biotechnologies、Arbutus Biopharma、Silent Therapeutics、Sylentis ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：リポソーム全身療法、ナノ粒子全身療法、その他 ・用途別分析2016年-2026年：病院、研究機関、製薬・バイオテクノロジー企業、学術機関、その他 ・低分子干渉RNA（siRNA）治療の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・低分子干渉RNA（siRNA）治療のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・低分子干渉RNA（siRNA）治療のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・低分子干渉RNA（siRNA）治療の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・低分子干渉RNA（siRNA）治療の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Small Interfering RNA (siRNA) Therapeutics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Small Interfering RNA (siRNA) Therapeutics size is estimated to be USD xx million in 2026 from USD xx million in 2020, with a change XX% between 2020 and 2021. The global Small Interfering RNA (siRNA) Therapeutics market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Small Interfering RNA (siRNA) Therapeutics market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Liposome Based Systemic Therapy
Nanoparticle Based Systemic Therapy
Other
Market segment by Application, can be divided into
Hospital
Research Institutions
Pharmaceutical and Biotechnology Companies
Academic Institutions
Other
Market segment by players, this report covers
GE
Horizon Discovery
Thermo Scientific
OPKO Health
AInylam Pharmaceuticals
Arrowhead Research
Sanofi Genzyme
Genecon Biotechnologies
Arbutus Biopharma
Silent Therapeutics
Sylentis
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
1 Market Overview
1.1 Product Overview and Scope of Small Interfering RNA (siRNA) Therapeutics
1.2 Classification of Small Interfering RNA (siRNA) Therapeutics by Type
1.2.1 Overview: Global Small Interfering RNA (siRNA) Therapeutics Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global Small Interfering RNA (siRNA) Therapeutics Revenue Market Share by Type in 2020
1.2.3 Liposome Based Systemic Therapy
1.2.4 Nanoparticle Based Systemic Therapy
1.2.5 Other
1.3 Global Small Interfering RNA (siRNA) Therapeutics Market by Application
1.3.1 Overview: Global Small Interfering RNA (siRNA) Therapeutics Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Hospital
1.3.3 Research Institutions
1.3.4 Pharmaceutical and Biotechnology Companies
1.3.5 Academic Institutions
1.3.6 Other
1.4 Global Small Interfering RNA (siRNA) Therapeutics Market Size & Forecast
1.5 Global Small Interfering RNA (siRNA) Therapeutics Market Size and Forecast by Region
1.5.1 Global Small Interfering RNA (siRNA) Therapeutics Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global Small Interfering RNA (siRNA) Therapeutics Market Size by Region, (2016-2021)
1.5.3 North America Small Interfering RNA (siRNA) Therapeutics Market Size and Prospect (2016-2026)
1.5.4 Europe Small Interfering RNA (siRNA) Therapeutics Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific Small Interfering RNA (siRNA) Therapeutics Market Size and Prospect (2016-2026)
1.5.6 South America Small Interfering RNA (siRNA) Therapeutics Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa Small Interfering RNA (siRNA) Therapeutics Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 Small Interfering RNA (siRNA) Therapeutics Market Drivers
1.6.2 Small Interfering RNA (siRNA) Therapeutics Market Restraints
1.6.3 Small Interfering RNA (siRNA) Therapeutics Trends Analysis
2 Company Profiles
2.1 GE
2.1.1 GE Details
2.1.2 GE Major Business
2.1.3 GE Small Interfering RNA (siRNA) Therapeutics Product and Solutions
2.1.4 GE Small Interfering RNA (siRNA) Therapeutics Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 GE Recent Developments and Future Plans
2.2 Horizon Discovery
2.2.1 Horizon Discovery Details
2.2.2 Horizon Discovery Major Business
2.2.3 Horizon Discovery Small Interfering RNA (siRNA) Therapeutics Product and Solutions
2.2.4 Horizon Discovery Small Interfering RNA (siRNA) Therapeutics Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 Horizon Discovery Recent Developments and Future Plans
2.3 Thermo Scientific
2.3.1 Thermo Scientific Details
2.3.2 Thermo Scientific Major Business
2.3.3 Thermo Scientific Small Interfering RNA (siRNA) Therapeutics Product and Solutions
2.3.4 Thermo Scientific Small Interfering RNA (siRNA) Therapeutics Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 Thermo Scientific Recent Developments and Future Plans
2.4 OPKO Health
2.4.1 OPKO Health Details
2.4.2 OPKO Health Major Business
2.4.3 OPKO Health Small Interfering RNA (siRNA) Therapeutics Product and Solutions
2.4.4 OPKO Health Small Interfering RNA (siRNA) Therapeutics Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 OPKO Health Recent Developments and Future Plans
2.5 AInylam Pharmaceuticals
2.5.1 AInylam Pharmaceuticals Details
2.5.2 AInylam Pharmaceuticals Major Business
2.5.3 AInylam Pharmaceuticals Small Interfering RNA (siRNA) Therapeutics Product and Solutions
2.5.4 AInylam Pharmaceuticals Small Interfering RNA (siRNA) Therapeutics Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 AInylam Pharmaceuticals Recent Developments and Future Plans
2.6 Arrowhead Research
2.6.1 Arrowhead Research Details
2.6.2 Arrowhead Research Major Business
2.6.3 Arrowhead Research Small Interfering RNA (siRNA) Therapeutics Product and Solutions
2.6.4 Arrowhead Research Small Interfering RNA (siRNA) Therapeutics Revenue, Gross Margin and Market Share (2019-2021)
2.6.5 Arrowhead Research Recent Developments and Future Plans
2.7 Sanofi Genzyme
2.7.1 Sanofi Genzyme Details
2.7.2 Sanofi Genzyme Major Business
2.7.3 Sanofi Genzyme Small Interfering RNA (siRNA) Therapeutics Product and Solutions
2.7.4 Sanofi Genzyme Small Interfering RNA (siRNA) Therapeutics Revenue, Gross Margin and Market Share (2019-2021)
2.7.5 Sanofi Genzyme Recent Developments and Future Plans
2.8 Genecon Biotechnologies
2.8.1 Genecon Biotechnologies Details
2.8.2 Genecon Biotechnologies Major Business
2.8.3 Genecon Biotechnologies Small Interfering RNA (siRNA) Therapeutics Product and Solutions
2.8.4 Genecon Biotechnologies Small Interfering RNA (siRNA) Therapeutics Revenue, Gross Margin and Market Share (2019-2021)
2.8.5 Genecon Biotechnologies Recent Developments and Future Plans
2.9 Arbutus Biopharma
2.9.1 Arbutus Biopharma Details
2.9.2 Arbutus Biopharma Major Business
2.9.3 Arbutus Biopharma Small Interfering RNA (siRNA) Therapeutics Product and Solutions
2.9.4 Arbutus Biopharma Small Interfering RNA (siRNA) Therapeutics Revenue, Gross Margin and Market Share (2019-2021)
2.9.5 Arbutus Biopharma Recent Developments and Future Plans
2.10 Silent Therapeutics
2.10.1 Silent Therapeutics Details
2.10.2 Silent Therapeutics Major Business
2.10.3 Silent Therapeutics Small Interfering RNA (siRNA) Therapeutics Product and Solutions
2.10.4 Silent Therapeutics Small Interfering RNA (siRNA) Therapeutics Revenue, Gross Margin and Market Share (2019-2021)
2.10.5 Silent Therapeutics Recent Developments and Future Plans
2.11 Sylentis
2.11.1 Sylentis Details
2.11.2 Sylentis Major Business
2.11.3 Sylentis Small Interfering RNA (siRNA) Therapeutics Product and Solutions
2.11.4 Sylentis Small Interfering RNA (siRNA) Therapeutics Revenue, Gross Margin and Market Share (2019-2021)
2.11.5 Sylentis Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Small Interfering RNA (siRNA) Therapeutics Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 3 Small Interfering RNA (siRNA) Therapeutics Players Market Share
3.2.2 Top 10 Small Interfering RNA (siRNA) Therapeutics Players Market Share
3.2.3 Market Competition Trend
3.3 Small Interfering RNA (siRNA) Therapeutics Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Small Interfering RNA (siRNA) Therapeutics Revenue and Market Share by Type (2016-2021)
4.2 Global Small Interfering RNA (siRNA) Therapeutics Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global Small Interfering RNA (siRNA) Therapeutics Revenue Market Share by Application (2016-2021)
5.2 Small Interfering RNA (siRNA) Therapeutics Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America Small Interfering RNA (siRNA) Therapeutics Revenue by Type (2016-2026)
6.2 North America Small Interfering RNA (siRNA) Therapeutics Revenue by Application (2016-2026)
6.3 North America Small Interfering RNA (siRNA) Therapeutics Market Size by Country
6.3.1 North America Small Interfering RNA (siRNA) Therapeutics Revenue by Country (2016-2026)
6.3.2 United States Small Interfering RNA (siRNA) Therapeutics Market Size and Forecast (2016-2026)
6.3.3 Canada Small Interfering RNA (siRNA) Therapeutics Market Size and Forecast (2016-2026)
6.3.4 Mexico Small Interfering RNA (siRNA) Therapeutics Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe Small Interfering RNA (siRNA) Therapeutics Revenue by Type (2016-2026)
7.2 Europe Small Interfering RNA (siRNA) Therapeutics Revenue by Application (2016-2026)
7.3 Europe Small Interfering RNA (siRNA) Therapeutics Market Size by Country
7.3.1 Europe Small Interfering RNA (siRNA) Therapeutics Revenue by Country (2016-2026)
7.3.2 Germany Small Interfering RNA (siRNA) Therapeutics Market Size and Forecast (2016-2026)
7.3.3 France Small Interfering RNA (siRNA) Therapeutics Market Size and Forecast (2016-2026)
7.3.4 United Kingdom Small Interfering RNA (siRNA) Therapeutics Market Size and Forecast (2016-2026)
7.3.5 Russia Small Interfering RNA (siRNA) Therapeutics Market Size and Forecast (2016-2026)
7.3.6 Italy Small Interfering RNA (siRNA) Therapeutics Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Small Interfering RNA (siRNA) Therapeutics Revenue by Type (2016-2026)
8.2 Asia-Pacific Small Interfering RNA (siRNA) Therapeutics Revenue by Application (2016-2026)
8.3 Asia-Pacific Small Interfering RNA (siRNA) Therapeutics Market Size by Region
8.3.1 Asia-Pacific Small Interfering RNA (siRNA) Therapeutics Revenue by Region (2016-2026)
8.3.2 China Small Interfering RNA (siRNA) Therapeutics Market Size and Forecast (2016-2026)
8.3.3 Japan Small Interfering RNA (siRNA) Therapeutics Market Size and Forecast (2016-2026)
8.3.4 South Korea Small Interfering RNA (siRNA) Therapeutics Market Size and Forecast (2016-2026)
8.3.5 India Small Interfering RNA (siRNA) Therapeutics Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia Small Interfering RNA (siRNA) Therapeutics Market Size and Forecast (2016-2026)
8.3.7 Australia Small Interfering RNA (siRNA) Therapeutics Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America Small Interfering RNA (siRNA) Therapeutics Revenue by Type (2016-2026)
9.2 South America Small Interfering RNA (siRNA) Therapeutics Revenue by Application (2016-2026)
9.3 South America Small Interfering RNA (siRNA) Therapeutics Market Size by Country
9.3.1 South America Small Interfering RNA (siRNA) Therapeutics Revenue by Country (2016-2026)
9.3.2 Brazil Small Interfering RNA (siRNA) Therapeutics Market Size and Forecast (2016-2026)
9.3.3 Argentina Small Interfering RNA (siRNA) Therapeutics Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Small Interfering RNA (siRNA) Therapeutics Revenue by Type (2016-2026)
10.2 Middle East & Africa Small Interfering RNA (siRNA) Therapeutics Revenue by Application (2016-2026)
10.3 Middle East & Africa Small Interfering RNA (siRNA) Therapeutics Market Size by Country
10.3.1 Middle East & Africa Small Interfering RNA (siRNA) Therapeutics Revenue by Country (2016-2026)
10.3.2 Turkey Small Interfering RNA (siRNA) Therapeutics Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia Small Interfering RNA (siRNA) Therapeutics Market Size and Forecast (2016-2026)
10.3.4 UAE Small Interfering RNA (siRNA) Therapeutics Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
Table 1. Global Small Interfering RNA (siRNA) Therapeutics Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global Small Interfering RNA (siRNA) Therapeutics Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market Small Interfering RNA (siRNA) Therapeutics Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global Small Interfering RNA (siRNA) Therapeutics Revenue (USD Million) by Region (2016-2021)
Table 5. Global Small Interfering RNA (siRNA) Therapeutics Revenue Market Share by Region (2021-2026)
Table 6. GE Corporate Information, Head Office, and Major Competitors
Table 7. GE Major Business
Table 8. GE Small Interfering RNA (siRNA) Therapeutics Product and Solutions
Table 9. GE Small Interfering RNA (siRNA) Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. Horizon Discovery Corporate Information, Head Office, and Major Competitors
Table 11. Horizon Discovery Major Business
Table 12. Horizon Discovery Small Interfering RNA (siRNA) Therapeutics Product and Solutions
Table 13. Horizon Discovery Small Interfering RNA (siRNA) Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 14. Thermo Scientific Corporate Information, Head Office, and Major Competitors
Table 15. Thermo Scientific Major Business
Table 16. Thermo Scientific Small Interfering RNA (siRNA) Therapeutics Product and Solutions
Table 17. Thermo Scientific Small Interfering RNA (siRNA) Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 18. OPKO Health Corporate Information, Head Office, and Major Competitors
Table 19. OPKO Health Major Business
Table 20. OPKO Health Small Interfering RNA (siRNA) Therapeutics Product and Solutions
Table 21. OPKO Health Small Interfering RNA (siRNA) Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 22. AInylam Pharmaceuticals Corporate Information, Head Office, and Major Competitors
Table 23. AInylam Pharmaceuticals Major Business
Table 24. AInylam Pharmaceuticals Small Interfering RNA (siRNA) Therapeutics Product and Solutions
Table 25. AInylam Pharmaceuticals Small Interfering RNA (siRNA) Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 26. Arrowhead Research Corporate Information, Head Office, and Major Competitors
Table 27. Arrowhead Research Major Business
Table 28. Arrowhead Research Small Interfering RNA (siRNA) Therapeutics Product and Solutions
Table 29. Arrowhead Research Small Interfering RNA (siRNA) Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 30. Sanofi Genzyme Corporate Information, Head Office, and Major Competitors
Table 31. Sanofi Genzyme Major Business
Table 32. Sanofi Genzyme Small Interfering RNA (siRNA) Therapeutics Product and Solutions
Table 33. Sanofi Genzyme Small Interfering RNA (siRNA) Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 34. Genecon Biotechnologies Corporate Information, Head Office, and Major Competitors
Table 35. Genecon Biotechnologies Major Business
Table 36. Genecon Biotechnologies Small Interfering RNA (siRNA) Therapeutics Product and Solutions
Table 37. Genecon Biotechnologies Small Interfering RNA (siRNA) Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 38. Arbutus Biopharma Corporate Information, Head Office, and Major Competitors
Table 39. Arbutus Biopharma Major Business
Table 40. Arbutus Biopharma Small Interfering RNA (siRNA) Therapeutics Product and Solutions
Table 41. Arbutus Biopharma Small Interfering RNA (siRNA) Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 42. Silent Therapeutics Corporate Information, Head Office, and Major Competitors
Table 43. Silent Therapeutics Major Business
Table 44. Silent Therapeutics Small Interfering RNA (siRNA) Therapeutics Product and Solutions
Table 45. Silent Therapeutics Small Interfering RNA (siRNA) Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 46. Sylentis Corporate Information, Head Office, and Major Competitors
Table 47. Sylentis Major Business
Table 48. Sylentis Small Interfering RNA (siRNA) Therapeutics Product and Solutions
Table 49. Sylentis Small Interfering RNA (siRNA) Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 50. Global Small Interfering RNA (siRNA) Therapeutics Revenue (USD Million) by Players (2019-2021)
Table 51. Global Small Interfering RNA (siRNA) Therapeutics Revenue Share by Players (2019-2021)
Table 52. Breakdown of Small Interfering RNA (siRNA) Therapeutics by Company Type (Tier 1, Tier 2 and Tier 3)
Table 53. Small Interfering RNA (siRNA) Therapeutics Players Head Office, Products and Services Provided
Table 54. Small Interfering RNA (siRNA) Therapeutics Mergers & Acquisitions in the Past Five Years
Table 55. Small Interfering RNA (siRNA) Therapeutics New Entrants and Expansion Plans
Table 56. Global Small Interfering RNA (siRNA) Therapeutics Revenue (USD Million) by Type (2016-2021)
Table 57. Global Small Interfering RNA (siRNA) Therapeutics Revenue Share by Type (2016-2021)
Table 58. Global Small Interfering RNA (siRNA) Therapeutics Revenue Forecast by Type (2021-2026)
Table 59. Global Small Interfering RNA (siRNA) Therapeutics Revenue by Application (2016-2021)
Table 60. Global Small Interfering RNA (siRNA) Therapeutics Revenue Forecast by Application (2021-2026)
Table 61. North America Small Interfering RNA (siRNA) Therapeutics Revenue by Type (2016-2021) & (USD Million)
Table 62. North America Small Interfering RNA (siRNA) Therapeutics Revenue by Type (2021-2026) & (USD Million)
Table 63. North America Small Interfering RNA (siRNA) Therapeutics Revenue by Application (2016-2021) & (USD Million)
Table 64. North America Small Interfering RNA (siRNA) Therapeutics Revenue by Application (2021-2026) & (USD Million)
Table 65. North America Small Interfering RNA (siRNA) Therapeutics Revenue by Country (2016-2021) & (USD Million)
Table 66. North America Small Interfering RNA (siRNA) Therapeutics Revenue by Country (2021-2026) & (USD Million)
Table 67. Europe Small Interfering RNA (siRNA) Therapeutics Revenue by Type (2016-2021) & (USD Million)
Table 68. Europe Small Interfering RNA (siRNA) Therapeutics Revenue by Type (2021-2026) & (USD Million)
Table 69. Europe Small Interfering RNA (siRNA) Therapeutics Revenue by Application (2016-2021) & (USD Million)
Table 70. Europe Small Interfering RNA (siRNA) Therapeutics Revenue by Application (2021-2026) & (USD Million)
Table 71. Europe Small Interfering RNA (siRNA) Therapeutics Revenue by Country (2016-2021) & (USD Million)
Table 72. Europe Small Interfering RNA (siRNA) Therapeutics Revenue by Country (2021-2026) & (USD Million)
Table 73. Asia-Pacific Small Interfering RNA (siRNA) Therapeutics Revenue by Type (2016-2021) & (USD Million)
Table 74. Asia-Pacific Small Interfering RNA (siRNA) Therapeutics Revenue by Type (2021-2026) & (USD Million)
Table 75. Asia-Pacific Small Interfering RNA (siRNA) Therapeutics Revenue by Application (2016-2021) & (USD Million)
Table 76. Asia-Pacific Small Interfering RNA (siRNA) Therapeutics Revenue by Application (2021-2026) & (USD Million)
Table 77. Asia-Pacific Small Interfering RNA (siRNA) Therapeutics Revenue by Region (2016-2021) & (USD Million)
Table 78. Asia-Pacific Small Interfering RNA (siRNA) Therapeutics Revenue by Region (2021-2026) & (USD Million)
Table 79. South America Small Interfering RNA (siRNA) Therapeutics Revenue by Type (2016-2021) & (USD Million)
Table 80. South America Small Interfering RNA (siRNA) Therapeutics Revenue by Type (2021-2026) & (USD Million)
Table 81. South America Small Interfering RNA (siRNA) Therapeutics Revenue by Application (2016-2021) & (USD Million)
Table 82. South America Small Interfering RNA (siRNA) Therapeutics Revenue by Application (2021-2026) & (USD Million)
Table 83. South America Small Interfering RNA (siRNA) Therapeutics Revenue by Country (2016-2021) & (USD Million)
Table 84. South America Small Interfering RNA (siRNA) Therapeutics Revenue by Country (2021-2026) & (USD Million)
Table 85. Middle East & Africa Small Interfering RNA (siRNA) Therapeutics Revenue by Type (2016-2021) & (USD Million)
Table 86. Middle East & Africa Small Interfering RNA (siRNA) Therapeutics Revenue by Type (2021-2026) & (USD Million)
Table 87. Middle East & Africa Small Interfering RNA (siRNA) Therapeutics Revenue by Application (2016-2021) & (USD Million)
Table 88. Middle East & Africa Small Interfering RNA (siRNA) Therapeutics Revenue by Application (2021-2026) & (USD Million)
Table 89. Middle East & Africa Small Interfering RNA (siRNA) Therapeutics Revenue by Country (2016-2021) & (USD Million)
Table 90. Middle East & Africa Small Interfering RNA (siRNA) Therapeutics Revenue by Country (2021-2026) & (USD Million)
List of Figures
Figure 1. Small Interfering RNA (siRNA) Therapeutics Picture
Figure 2. Global Small Interfering RNA (siRNA) Therapeutics Revenue Market Share by Type in 2020
Figure 3. Liposome Based Systemic Therapy
Figure 4. Nanoparticle Based Systemic Therapy
Figure 5. Other
Figure 6. Small Interfering RNA (siRNA) Therapeutics Revenue Market Share by Application in 2020
Figure 7. Hospital Picture
Figure 8. Research Institutions Picture
Figure 9. Pharmaceutical and Biotechnology Companies Picture
Figure 10. Academic Institutions Picture
Figure 11. Other Picture
Figure 12. Global Small Interfering RNA (siRNA) Therapeutics Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 13. Global Small Interfering RNA (siRNA) Therapeutics Revenue and Forecast (2016-2026) & (USD Million)
Figure 14. Global Small Interfering RNA (siRNA) Therapeutics Revenue Market Share by Region (2016-2026)
Figure 15. Global Small Interfering RNA (siRNA) Therapeutics Revenue Market Share by Region in 2020
Figure 16. North America Small Interfering RNA (siRNA) Therapeutics Revenue (USD Million) and Growth Rate (2016-2026)
Figure 17. Europe Small Interfering RNA (siRNA) Therapeutics Revenue (USD Million) and Growth Rate (2016-2026)
Figure 18. Asia-Pacific Small Interfering RNA (siRNA) Therapeutics Revenue (USD Million) and Growth Rate (2016-2026)
Figure 19. South America Small Interfering RNA (siRNA) Therapeutics Revenue (USD Million) and Growth Rate (2016-2026)
Figure 20. Middle East and Africa Small Interfering RNA (siRNA) Therapeutics Revenue (USD Million) and Growth Rate (2016-2026)
Figure 21. Small Interfering RNA (siRNA) Therapeutics Market Drivers
Figure 22. Small Interfering RNA (siRNA) Therapeutics Market Restraints
Figure 23. Small Interfering RNA (siRNA) Therapeutics Market Trends
Figure 24. GE Recent Developments and Future Plans
Figure 25. Horizon Discovery Recent Developments and Future Plans
Figure 26. Thermo Scientific Recent Developments and Future Plans
Figure 27. OPKO Health Recent Developments and Future Plans
Figure 28. AInylam Pharmaceuticals Recent Developments and Future Plans
Figure 29. Arrowhead Research Recent Developments and Future Plans
Figure 30. Sanofi Genzyme Recent Developments and Future Plans
Figure 31. Genecon Biotechnologies Recent Developments and Future Plans
Figure 32. Arbutus Biopharma Recent Developments and Future Plans
Figure 33. Silent Therapeutics Recent Developments and Future Plans
Figure 34. Sylentis Recent Developments and Future Plans
Figure 35. Global Small Interfering RNA (siRNA) Therapeutics Revenue Share by Players in 2020
Figure 36. Small Interfering RNA (siRNA) Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 37. Global Top 3 Players Small Interfering RNA (siRNA) Therapeutics Revenue Market Share in 2020
Figure 38. Global Top 10 Players Small Interfering RNA (siRNA) Therapeutics Revenue Market Share in 2020
Figure 39. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 40. Global Small Interfering RNA (siRNA) Therapeutics Revenue Share by Type in 2020
Figure 41. Global Small Interfering RNA (siRNA) Therapeutics Market Share Forecast by Type (2021-2026)
Figure 42. Global Small Interfering RNA (siRNA) Therapeutics Revenue Share by Application in 2020
Figure 43. Global Small Interfering RNA (siRNA) Therapeutics Market Share Forecast by Application (2021-2026)
Figure 44. North America Small Interfering RNA (siRNA) Therapeutics Sales Market Share by Type (2016-2026)
Figure 45. North America Small Interfering RNA (siRNA) Therapeutics Sales Market Share by Application (2016-2026)
Figure 46. North America Small Interfering RNA (siRNA) Therapeutics Revenue Market Share by Country (2016-2026)
Figure 47. United States Small Interfering RNA (siRNA) Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 48. Canada Small Interfering RNA (siRNA) Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 49. Mexico Small Interfering RNA (siRNA) Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 50. Europe Small Interfering RNA (siRNA) Therapeutics Sales Market Share by Type (2016-2026)
Figure 51. Europe Small Interfering RNA (siRNA) Therapeutics Sales Market Share by Application (2016-2026)
Figure 52. Europe Small Interfering RNA (siRNA) Therapeutics Revenue Market Share by Country (2016-2026)
Figure 53. Germany Small Interfering RNA (siRNA) Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 54. France Small Interfering RNA (siRNA) Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 55. United Kingdom Small Interfering RNA (siRNA) Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 56. Russia Small Interfering RNA (siRNA) Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 57. Italy Small Interfering RNA (siRNA) Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 58. Asia-Pacific Small Interfering RNA (siRNA) Therapeutics Sales Market Share by Type (2016-2026)
Figure 59. Asia-Pacific Small Interfering RNA (siRNA) Therapeutics Sales Market Share by Application (2016-2026)
Figure 60. Asia-Pacific Small Interfering RNA (siRNA) Therapeutics Revenue Market Share by Region (2016-2026)
Figure 61. China Small Interfering RNA (siRNA) Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. Japan Small Interfering RNA (siRNA) Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. South Korea Small Interfering RNA (siRNA) Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 64. India Small Interfering RNA (siRNA) Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 65. Southeast Asia Small Interfering RNA (siRNA) Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 66. Australia Small Interfering RNA (siRNA) Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 67. South America Small Interfering RNA (siRNA) Therapeutics Sales Market Share by Type (2016-2026)
Figure 68. South America Small Interfering RNA (siRNA) Therapeutics Sales Market Share by Application (2016-2026)
Figure 69. South America Small Interfering RNA (siRNA) Therapeutics Revenue Market Share by Country (2016-2026)
Figure 70. Brazil Small Interfering RNA (siRNA) Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 71. Argentina Small Interfering RNA (siRNA) Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 72. Middle East and Africa Small Interfering RNA (siRNA) Therapeutics Sales Market Share by Type (2016-2026)
Figure 73. Middle East and Africa Small Interfering RNA (siRNA) Therapeutics Sales Market Share by Application (2016-2026)
Figure 74. Middle East and Africa Small Interfering RNA (siRNA) Therapeutics Revenue Market Share by Country (2016-2026)
Figure 75. Turkey Small Interfering RNA (siRNA) Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 76. Saudi Arabia Small Interfering RNA (siRNA) Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 77. UAE Small Interfering RNA (siRNA) Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 78. Methodology
Figure 79. Research Process and Data Source
扁平上皮非小細胞肺がん治療法市場：世界及び中国市場分析・予測（～2024年） Squamous Non-Small Cell Lung Cancer Therapeutics Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global Squamous Non-Small Cell Lung Cancer Therapeutics industry with a focus on the Chinese market. The report provides key statistics …- 世界の皮膚・全身性リーシュマニア症治療薬市場 2021：企業別、地域別、種類・用途別 The Cutaneous and Systemic Leishmaniasis Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimiza…
- 世界のCAR T細胞療法市場 2021：企業別、地域別、種類・用途別 The CAR T-Cell Therapy market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations,…
- 世界のTCR療法市場 2021：企業別、地域別、種類・用途別 The TCR Therapy market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent…
- 世界の遺伝子治療薬市場 2021：企業別、地域別、種類・用途別 The Gene Therapy Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations,…